November 27, 2014 | Teva Pharmaceutical Industries announced that the board of directors has elected Professor Yitzhak Peterburg as chairman, becoming effective on January 1, 2015. Prof. Peterburg has been a member of the board since 2012 and will replace Dr. Phillip Frost. In addition, the board appointed Dr. Sol J. Barer to the position of director of the board. Prof. Peterburg has previously served as the CEO and president of the Israeli mobile carrier Cellcom from 2003-2005.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments